This inventor holds 1 USPTO granted patent. Top assignee: Rhizen Pharmaceuticals Sa. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kanthikiran V S Varanasi: Innovator in Cancer Treatment
Introduction
Kanthikiran V S Varanasi is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on novel therapeutic approaches that aim to improve patient outcomes in oncology.
Latest Patents
Kanthikiran holds a patent for "Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer." This patent discloses novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, as well as methods for identifying therapeutics for treating and diagnosing cancer. He has 1 patent to his name.
Career Highlights
Kanthikiran is currently associated with Rhizen Pharmaceuticals SA, where he continues to advance his research in cancer therapeutics. His work is characterized by a commitment to developing effective treatments that can significantly impact the lives of patients suffering from cancer.
Collaborations
He collaborates with notable colleagues, including Meyyappan Muthuppalaniappan and Srikant Viswanadha, who contribute to his research endeavors and help drive innovation in the field.
Conclusion
Kanthikiran V S Varanasi is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in medicine. His contributions through patents and collaborations highlight his commitment to improving healthcare outcomes for patients with non-small cell lung cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
